跳至主要内容
临床试验/IRCT20190707044123N1
IRCT20190707044123N1已完成3 期

Clinical trial on the effectiveness of the Famotidine on symptoms of schizophrenic patients

Rasht University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 50 years(—)
性别
All

入选标准

  • The diagnosis of schizophrenia based on Diagnostic and Statistical Manual of Psychiatric Disorders (DSM5)
  • Patients receiving second-generation drugs
  • A year past diagnosis of schizophrenia
  • Patients have a secondary school education

排除标准

  • Sensitivity to famotidine
  • Serious medical illness (Nephrology disease)

研究者

发起方
Rasht University of Medical Sciences

相似试验

Clinical trial on the effectiveness of the... | 临床试验